Integrum (publ) announced that the European Union Intellectual Property Office, EUIPO, has approved Integrum's product registration application for the OPRA® Implant System. Until now, the OPRA® Implant system has been an unregistered mark without legal protection. As it is granted a registered trademark, Integrum now obtains unitary immaterial protection for the product in the entire territory of the EU.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.8 SEK | -1.55% | -4.87% | +11.28% |
05-29 | Integrum Receives Market Approval for Opra®? Implant System in Israel | CI |
05-15 | Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.28% | 88.9M | |
-13.72% | 20.65B | |
+3.79% | 18.79B | |
+8.00% | 14.03B | |
-20.38% | 1.99B | |
+3.10% | 1.76B | |
+8.31% | 1.33B | |
+6.05% | 552M | |
-.--% | 421M | |
+69.47% | 196M |
- Stock Market
- Equities
- INTEG B Stock
- News Integrum AB
- Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu